[The treatment of the pseudocroup syndrome (author's transl)].
The results of the implementation of Myoscain E/Holzinger in the treatment of the "pseudocroup syndrome" (laryngitis catarrhalis) are reported. The generally prompt action of the drug is stressed. It is pointed out that non-response to the compound suggests a more serious form of the disease necessitating close observation. A list of diseases involved in the differential diagnosis is added.